Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol vs brinzolamide added to travoprost in primary open-angle glaucoma or ocular hypertension
2005-004201-29Phase 4Terminated
- Sponsor
- Alcon Inc.
- Start
- Jan 2006
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in open-angle glaucoma (OAG) and ocular hypertension comparing Travatan + Cusimolol with Travatan + Azopt (2 arms). Started Jan 2006; status: terminated.
02
Drugs
travoprostbrinzolamidetimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2005-004201-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004201-29.